Epidemiology and long-term survival of pulmonary arterial
hypertension in the Czech Republic: a retrospective analysis of
a nationwide registry

J 2014

Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry

JANSA, P.; Jiří JARKOVSKÝ; Hikmet AL-HITI; Jana POPELOVA; David AMBROZ et al.

Základní údaje

Originální název

Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry

Autoři

Vydání

BMC PULMONARY MEDICINE, LONDON, BIOMED CENTRAL LTD, 2014, 1471-2466

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 2.404

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/14:00075702

Organizační jednotka

Lékařská fakulta

DOI

https://doi.org/10.1186/1471-2466-14-45

UT WoS

000335359200001

EID Scopus

2-s2.0-84899154026

Klíčová slova anglicky

Pulmonary arterial hypertension; Epidemiology; Survival; Czech Republic; National registry

Štítky

EL OK

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 12. 6. 2014 15:48, Soňa Böhmová

Anotace

V originále

Background: Pulmonary arterial hypertension (PAH) is a severe and progressive disease characterized by increased pulmonary vascular resistance, ultimately leading to right heart failure and death. Epidemiological data from national registries are growing worldwide, but are still unavailable in Eastern Europe. Methods: A PAH registry was initiated in January 2007 using a nationwide network of echocardiographic centers and four diagnostic centers that specialize in PAH. All patients aged above 18 years, diagnosed with PAH and monitored between January 2000 and December 2007 were included. Patients diagnosed with PAH between January and December 2007 were classified as incident. The survival analyses were performed up to the end of 2010. Prognostic factors at the time of diagnosis were identified using uni-and multivariable Cox proportional hazard models. Results: Overall, 191 patients were included (100 prevalent cases, 91 incident cases). Patients were predominantly female (n = 125) and had a mean age of 51.9 +/- 16.9 years. Incident patients were significantly older at the time of diagnosis than prevalent patients (p < 0.001). Most patients (60.7%) had idiopathic PAH; 20.4% had PAH associated with congenital heart disease and 11.4% had PAH associated with connective tissue disease. Estimates of prevalence and incidence of PAH in adults were 22.4 cases per million and 10.7 cases per million per year, respectively. The 1-, 2-and 3-year survival rates in the incident PAH cohort were 89% (95% confidence intervals [CI] 83-95%), 78% (95% CI 70-87%) and 74% (95% CI 65-83%), respectively. Lower survival rates were significantly associated with higher age (hazard ratio [HR] 6.6 95% CI 1.4-30.9) and lower creatinine clearance (HR 3.3 95% CI 1.1-9.7). Conclusion: This is the first study in Eastern Europe to describe the prevalence, incidence and survival of patients with PAH from a national representative registry. This registry from the Czech Republic highlights that diagnosis of PAH is frequently made late in the disease continuum when patients have significant functional impairment.

Citovat

JANSA, P.; Jiří JARKOVSKÝ; Hikmet AL-HITI; Jana POPELOVA; David AMBROZ; Tomáš ZATOČIL; Regina VOTAVOVA; Pavel POLACEK; Jana MARESOVA; Michael ASCHERMANN; Petr BRABEC; Ladislav DUŠEK a Aleš LINHART. Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry. BMC PULMONARY MEDICINE. LONDON: BIOMED CENTRAL LTD, 2014, roč. 14, "article number" 45, s. 1-9. ISSN 1471-2466. Dostupné z: https://doi.org/10.1186/1471-2466-14-45.

@article{1185590,
   author = {Jansa, P. and Jarkovský, Jiří and AlandHiti, Hikmet and Popelova, Jana and Ambroz, David and Zatočil, Tomáš and Votavova, Regina and Polacek, Pavel and Maresova, Jana and Aschermann, Michael and Brabec, Petr and Dušek, Ladislav and Linhart, Aleš},
   article_location = {LONDON},
   article_number = {"article number" 45},
   doi = {https://doi.org/10.1186/1471-2466-14-45},
   keywords = {Pulmonary arterial hypertension; Epidemiology; Survival; Czech Republic; National registry},
   language = {eng},
   issn = {1471-2466},
   journal = {BMC PULMONARY MEDICINE},
   title = {Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry},
   volume = {14},
   year = {2014}
}

TY  - JOUR
ID  - 1185590
AU  - Jansa, P. - Jarkovský, Jiří - Al-Hiti, Hikmet - Popelova, Jana - Ambroz, David - Zatočil, Tomáš - Votavova, Regina - Polacek, Pavel - Maresova, Jana - Aschermann, Michael - Brabec, Petr - Dušek, Ladislav - Linhart, Aleš
PY  - 2014
TI  - Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry
JF  - BMC PULMONARY MEDICINE
VL  - 14
IS  - "article number" 45
SP  - 1-9
EP  - 1-9
PB  - BIOMED CENTRAL LTD
SN  - 14712466
KW  - Pulmonary arterial hypertension
KW  - Epidemiology
KW  - Survival
KW  - Czech Republic
KW  - National registry
N2  - Background: Pulmonary arterial hypertension (PAH) is a severe and progressive disease characterized by increased pulmonary vascular resistance, ultimately leading to right heart failure and death. Epidemiological data from national registries are growing worldwide, but are still unavailable in Eastern Europe. Methods: A PAH registry was initiated in January 2007 using a nationwide network of echocardiographic centers and four diagnostic centers that specialize in PAH. All patients aged above 18 years, diagnosed with PAH and monitored between January 2000 and December 2007 were included. Patients diagnosed with PAH between January and December 2007 were classified as incident. The survival analyses were performed up to the end of 2010. Prognostic factors at the time of diagnosis were identified using uni-and multivariable Cox proportional hazard models. Results: Overall, 191 patients were included (100 prevalent cases, 91 incident cases). Patients were predominantly female (n = 125) and had a mean age of 51.9 +/- 16.9 years. Incident patients were significantly older at the time of diagnosis than prevalent patients (p < 0.001). Most patients (60.7%) had idiopathic PAH; 20.4% had PAH associated with congenital heart disease and 11.4% had PAH associated with connective tissue disease. Estimates of prevalence and incidence of PAH in adults were 22.4 cases per million and 10.7 cases per million per year, respectively. The 1-, 2-and 3-year survival rates in the incident PAH cohort were 89% (95% confidence intervals [CI] 83-95%), 78% (95% CI 70-87%) and 74% (95% CI 65-83%), respectively. Lower survival rates were significantly associated with higher age (hazard ratio [HR] 6.6 95% CI 1.4-30.9) and lower creatinine clearance (HR 3.3 95% CI 1.1-9.7). Conclusion: This is the first study in Eastern Europe to describe the prevalence, incidence and survival of patients with PAH from a national representative registry. This registry from the Czech Republic highlights that diagnosis of PAH is frequently made late in the disease continuum when patients have significant functional impairment.
ER  -

JANSA, P.; Jiří JARKOVSKÝ; Hikmet AL-HITI; Jana POPELOVA; David AMBROZ; Tomáš ZATOČIL; Regina VOTAVOVA; Pavel POLACEK; Jana MARESOVA; Michael ASCHERMANN; Petr BRABEC; Ladislav DUŠEK a Aleš LINHART. Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry. \textit{BMC PULMONARY MEDICINE}. LONDON: BIOMED CENTRAL LTD, 2014, roč.~14, ''article number'' 45, s.~1-9. ISSN~1471-2466. Dostupné z: https://doi.org/10.1186/1471-2466-14-45.

Přehled o publikaci